Amy Holleman

Title: Amy Holleman: Innovator in Cancer Treatment

Introduction

Amy Holleman is a notable inventor based in Woudenberg, Netherlands. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of taxane-resistant cancers. Her innovative work has the potential to improve treatment outcomes for patients facing this challenging condition.

Latest Patents

Amy Holleman holds a patent for her work titled "Diagnosis and treatment of taxane-resistant cancers." This patent outlines methods and assays that relate to diagnosing and treating cancers that are resistant to taxane therapies. The methods involve determining the level of expression of miR-135 in biological samples from subjects with or suspected of having taxane-resistant cancer. Additionally, her patent includes methods for treating such cancers by administering an inhibitor of the miR-135 pathway alongside a taxane to patients in need.

Career Highlights

Amy is associated with the Children's Medical Center Corporation, where she continues to advance her research in cancer treatment. Her dedication to improving patient care through innovative solutions is evident in her work and contributions to the medical community.

Collaborations

Amy has collaborated with esteemed colleagues, including Bruce R Zetter and Ivy Chung. These partnerships have further enriched her research and expanded the impact of her innovations in the field of oncology.

Conclusion

Amy Holleman's work exemplifies the vital role of inventors in advancing medical science. Her patent on taxane-resistant cancers showcases her commitment to finding effective treatments for patients. Through her career and collaborations, she continues to make a significant impact in the fight against cancer.